[PHAS] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[PHAS] PhaseBio Pharmaceuticals, Inc.
Announcement Date
29-Sep-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ-
YoY-
Quarter Report
PHAS's Result
PHAS's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 335 241 241 411 0 -
PBT -31,924 -25,143 -11,391 -7,901 -2,560 87.83%
Tax -3,126 -4,289 465 -2,012 -47 185.37%
NP -31,924 -25,143 -11,391 -7,901 -2,560 87.83%
Tax Rate - - - - - -
Total Cost 32,259 25,384 11,632 8,312 2,560 88.32%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -9,529.55 -10,432.78 -4,726.56 -1,922.38 0.00 -
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.66 -0.86 -0.40 -0.40 -0.21 33.12%
EPS Diluted -0.66 -0.86 -0.40 -0.40 -0.21 33.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.